How to manage a losing position in Century Therapeutics Inc. - Earnings Summary Report Free Community Consensus Stock Picks - newser.com
IPSC Stock | USD 0.54 0.02 3.57% |
About 62% of Century Therapeutics' investor base is looking to short. The analysis of current outlook of investing in Century Therapeutics suggests that many traders are alarmed regarding Century Therapeutics' prospects. The current market sentiment, together with Century Therapeutics' historical and current headlines, can help investors time the market. In addition, many technical investors use Century Therapeutics stock news signals to limit their universe of possible portfolio assets.
How to manage a losing position in Century Therapeutics Inc. - Earnings Summary Report Free Community Consensus Stock Picks newser.com
Read at news.google.com
![]() |
Century Therapeutics Fundamental Analysis
We analyze Century Therapeutics' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Century Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Century Therapeutics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Shares Owned By Insiders
Shares Owned By Insiders Comparative Analysis
Century Therapeutics is currently under evaluation in shares owned by insiders category among its peers. Shares Owned by Insiders show the percentage of outstanding shares owned by insiders (such as principal officers or members of the board of directors) or private individuals and entities with over 5% of the total shares outstanding. Company executives or private individuals with access to insider information share information about a firm's operations that is not available to the general public.
Century Therapeutics Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Century Therapeutics stock to make a market-neutral strategy. Peer analysis of Century Therapeutics could also be used in its relative valuation, which is a method of valuing Century Therapeutics by comparing valuation metrics with similar companies.
Peers
Century Therapeutics Related Equities
BCAB | Bioatla | 12.16 | ||||
CALC | CalciMedica, Common | 1.23 | ||||
MDCX | Medicus Pharma | 2.07 | ||||
INMB | INmune Bio | 4.15 | ||||
SKYE | Skye Bioscience, | 4.83 | ||||
MAIA | MAIA Biotechnology | 5.19 | ||||
ATNM | Actinium Pharmaceuticals | 5.81 | ||||
LTRN | Lantern Pharma | 8.10 | ||||
QTTB | Q32 Bio | 11.94 | ||||
EVAX | Evaxion Biotech | 29.27 |
Complementary Tools for Century Stock analysis
When running Century Therapeutics' price analysis, check to measure Century Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Century Therapeutics is operating at the current time. Most of Century Therapeutics' value examination focuses on studying past and present price action to predict the probability of Century Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Century Therapeutics' price. Additionally, you may evaluate how the addition of Century Therapeutics to your portfolios can decrease your overall portfolio volatility.
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios |